These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10905554)

  • 21. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
    Aukunuru JV; Ayalasomayajula SP; Kompella UB
    J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.
    Bennett CF; Mirejovsky D; Crooke RM; Tsai YJ; Felgner J; Sridhar CN; Wheeler CJ; Felgner PL
    J Drug Target; 1998; 5(3):149-62. PubMed ID: 9606005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery of antisense oligonucleotides using cholesterol-modified sense dendrimers and cationic lipids.
    Chaltin P; Margineanu A; Marchand D; Van Aerschot A; Rozenski J; De Schryver F; Herrmann A; Müllen K; Juliano R; Fisher MH; Kang H; De Feyter S; Herdewijn P
    Bioconjug Chem; 2005; 16(4):827-36. PubMed ID: 16029024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel cationic amphiphiles as delivery agents for antisense oligonucleotides.
    DeLong RK; Yoo H; Alahari SK; Fisher M; Short SM; Kang SH; Kole R; Janout V; Regan SL; Juliano RL
    Nucleic Acids Res; 1999 Aug; 27(16):3334-41. PubMed ID: 10454641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates.
    Astriab-Fisher A; Sergueev DS; Fisher M; Shaw BR; Juliano RL
    Biochem Pharmacol; 2000 Jul; 60(1):83-90. PubMed ID: 10807948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania.
    Chakraborty R; Dasgupta D; Adhya S; Basu MK
    Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):393-6. PubMed ID: 10333480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the biological activity of anti-ICAM-1 oligonucleotides complexed to non-viral carriers.
    Lucas B; Van Rompaey E; Remaut K; Sanders N; De Smedt SC; Demeester J
    J Control Release; 2004 Apr; 96(1):207-19. PubMed ID: 15063042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
    Zhang C; Pei J; Kumar D; Sakabe I; Boudreau HE; Gokhale PC; Kasid UN
    Methods Mol Biol; 2007; 361():163-85. PubMed ID: 17172711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of multidrug-resistant murine leukemia with antisense mdr1 oligodeoxynucleotides.
    Hiratake S; Azuma E; Nishiguchi Y; Nagai M; Ido M; Komada Y; Sakurai M
    Biomed Pharmacother; 1997; 51(6-7):276-83. PubMed ID: 9309248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides.
    Thierry AR; Rahman A; Dritschilo A
    Biochem Biophys Res Commun; 1993 Feb; 190(3):952-60. PubMed ID: 8094959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent and selective gene inhibition using antisense oligodeoxynucleotides.
    Flanagan WM; Wagner RW
    Mol Cell Biochem; 1997 Jul; 172(1-2):213-25. PubMed ID: 9278247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells.
    Niu G; Castro CH; Nguyen N; Sullivan SM; Hughes JA
    J Drug Target; 2010 Jul; 18(6):468-76. PubMed ID: 20059301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P; Geiser TA; Ombres D; Citro G
    Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery.
    Zhao Q; Temsamani J; Agrawal S
    Antisense Res Dev; 1995; 5(3):185-92. PubMed ID: 8785474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Pluronic on cellular uptake of cationic liposomes- mediated antisense oligonucleotides.
    Chen HL; Hu QH; Liang WQ
    Pharmazie; 2004 Feb; 59(2):131-3. PubMed ID: 15025182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cationic nanoemulsion as a delivery system for oligonucleotides targeting malarial topoisomerase II.
    Bruxel F; Cojean S; Bochot A; Teixeira H; Bories C; Loiseau PM; Fattal E
    Int J Pharm; 2011 Sep; 416(2):402-9. PubMed ID: 21291974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
    Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY
    Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
    Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
    Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the human mdr1 gene by 125I-labeled triplex-forming oligonucleotides.
    Sedelnikova OA; Panyutin IG; Luu AN; Reed MW; Licht T; Gottesman MM; Neumann RD
    Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):443-52. PubMed ID: 11198928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.